Krista Kauppinen
VP, General Counsel & Head of Intellectual PropertyMs. Krista Kauppinen, Ph.D, J.D., is VP, General Counsel & Head of Intellectual Property of Century Therapeutics, Inc. from 2026. She brings more than 15 years of legal and intellectual property leadership experience to Century across the biotechnology and life sciences industry, with deep expertise supporting innovative cell and gene therapy organizations. Most recently, Krista served as Vice President, Head of Intellectual Property at Generation Bio, where she led strategy and management of a large global patent portfolio supporting non-viral gene therapy programs and strategic transactions and collaborations, including the Moderna partnership. She has also held senior legal and IP leadership roles at early-stage and public biotechnology companies, including serving as Associate General Counsel and Head of IP at Clade Therapeutics and Vice President of Legal Affairs and Corporate Secretary at Dark Horse Consulting Group. Krista holds a PhD in Biochemistry from Cornell University and a JD from the University of California, Davis School of Law and is admitted to practice in California, in Massachusetts (as a registered in-house counsel) and before the U.S. Patent and Trademark Office.
Positions
- Company NameCentury Therapeutics, Inc.Stock CodeIPSCPositionVP, General Counsel & Head of Intellectual PropertyColleagues
- BPBrent PfeiffenbergerPresident, CEO & Chairman
- GRGregory RussottiChief Technology & Manufacturing Officer
- CAChad A. CowanChief Scientific Officer
- DCDouglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary
- KLKimberly Lynn BlackwellLead Independent Director
- DEDaphne E. QuimiIndependent Director
- MPMartin Patrick MurphyIndependent Director
- JJJoseph JimenezSpecial Advisor to the Board
